• isibhengezo_sekhasi

Izindaba

U-Fluxergy wayeyilungu elisungula Uhlelo Lwelungu Lemboni (IPP) i-Wyss Diagnostic Accelerator (Wyss DxA).I-Wyss DxA iwuhlelo lwe-Wyss Institute e-Harvard University ukudala nokuletha ubuchwepheshe bokuxilonga obuphumelelayo ukuze kuhlangatshezwane nezidingo zomtholampilo ezingahlangatshezwana nazo ekuhlolweni, ekuxilongeni, ekuqaguleni, nasekulapheni.Ngokubamba iqhaza ku-IPP, i-Fluxergy ibambisana nabelaphi abavelele, abacwaningi, onjiniyela, izikhungo ezixhasa ngezimali, ama-philanthropists, izinhlangano zikahulumeni, nabalingani bemboni.
"Isilinganiso sempumelelo ye-Wyss Diagnostic Accelerator sisindisa izimpilo ngokuhlinzeka ngokuxilongwa okunembile nokuthengekayo, futhi lokho kuwumsebenzi wethu," kusho uDkt. Rushdi Ahmad, iNhloko ye-Wyss DxA.
I-Wyss DxA iholwa ngu-Ahmad noDkt. David Walt.UWalt uyilungu eliphambili lobuhlakani e-Wyss Institute, uprofesa wezifo eSibhedlela saseBrigham naseSibhedlela Sabesifazane, futhi ungumsunguli wesayensi wezinkampani ezimbalwa zesayensi yezempilo.Ngokubamba iqhaza ohlelweni, i-Fluxergy izosebenza ngaphakathi kwe-IPP ukwenza lula ukutholakala, ukuthuthukiswa kanye nokulethwa kwezixazululo zokuxilonga ezindaweni lapho isidingo singahlangatshezwana khona.
“Ngemva kokuhlangana kwami ​​kokuqala nozakwethu bokuqala, ngajabula.Sinesikhala esigcwele isisindo sesayensi nesokuhweba sokuqalisa izinguquko, ikakhulukazi ukufanisa izidingo ezingahlangatshezwana nobuchwepheshe obufunekayo.Ithuba lokujoyina iqembu eliqhutshwa ulwazi lomfelandawonye wabantu abacebile, abashisekayo lihlukile ngobungcweti obuhlukahlukene: izicelo empilweni yabantu, imithi yezilwane kanye nokuphepha kokudla, ukuba khona komhlaba wonke kuzo zonke izimakethe kanye nokufakwa kwe-telemedicine, ukuxilonga, ukutholakala kwemithi. nempilo yedijithali,” kusho uTej Patel, oyi-CEO kanye nomsunguli we-Fluxergy.
I-Fluxergy ihlose ukusebenzisa inkundla yayo yokuxilonga enezimo eziningi njengozakwethu we-OEM ukukhiqiza amaphaneli okuhlola ama-multi-ohm ahlanganisa inhlanganisela yamaprotheni, okulotshiweyo nama-metabolite abe amasiginesha ayingqayizivele ukuze azise kangcono iziguli ngemiphumela yokwelashwa.Izibonelo zezicelo zezempilo zabantu zingabonakala ezifweni ezithathelwanayo, izifo zegazi ezingapheli, umdlavuza, i-sepsis, nesifo sezinso esingamahlalakhona.Njengamanje, izinsiza zokunakekelwa kwempilo zingakhawulelwa ekunqumeni uhlobo olulodwa lwepharamitha (okungukuthi, i-immunoassay, ikhemistri, noma i-PCR).Amasistimu e-Fluxergy aguquguqukayo aklanyelwe ukwenza i-PCR, i-immunoassay, i-biochemistry nokubala kwamaseli endaweni eyodwa esebenziseka kalula.Kwezokunakekelwa kwempilo, i-Fluxergy ihlose ukusiza ukuthuthukisa amaphaneli okuhlola e-syndromic kanye nesimo futhi awenze atholakale ukuze asetshenziswe emitholampilo emincane, amahhovisi odokotela, amakhaya asebekhulile kanye nabathengi ukuze kuhlolwe okuyinkimbinkimbi, kusukela kumaphaneli ajwayelekile we-metabolic kuya ekuhlolweni kokuhlolwa kwe-sepsis.Lokhu ukunwetshwa kwengqalasizinda yelabhorethri emaphakathi okuzokwenza lula ukuthathwa kwezinqumo zomtholampilo ezisheshayo ngokusekelwe olwazini lwaselabhorethri.
UDkt. Ahmed uphethe umhlangano wokuphela konyaka ngokuthi, “Kwa-Wyss Diagnostic Accelerator, leli thimba linombono ongenakuqhathaniswa noyingqayizivele wokwenza ukuxilonga kufinyeleleke kuwo wonke umuntu.”
I-Fluxergy yinkampani yemishini yezokwelapha egxile kubuchwepheshe bokuthola indawo yokusetshenziswa ukuze inikeze ukuxilonga okuthengekayo kunoma yisiphi isilungiselelo.Uhlelo lwe-Fluxergy lusebenzisa i-microfluidics yobunikazi kanye nesistimu yezinzwa edidiyelwe kakhulu ukuze idale inkundla yokuhlola ye-multimodal eguquguqukayo futhi engabizi kakhulu.I-Fluxergy i-ISO 13485 futhi i-MDSAP iqinisekiswe ukukhiqizwa kwe-IVD. Ikhampasi yokukhiqiza ye-Fluxergy kanye ne-R&D ithatha indawo ka-90,000 sq.ft. Ikhampasi yokukhiqiza ye-Fluxergy kanye ne-R&D ithatha indawo ka-90,000 sq.ft.Ikhampasi yokukhiqiza nokucwaninga ye-Fluxergy ihlanganisa indawo engu-90,000 sq. ft.Ikhampasi yokukhiqiza nokucwaninga ye-Fluxergy ihlanganisa amamitha-skwele angama-90,000.e-Irvine, eCalifornia.I-Fluxergy Europe GMBH izinze e-Aschaffenburg, eJalimane.I-Fluxergy Inc. yasungulwa ngo-2013 ngoxhaso lwezezimali lomtshali-zimali oholayo kanye nomsunguli we-Kingston Technology, u-John Tu.
Uhlelo Lokuhlola I-Fluxergy Diagnostic luqukethe Ikhadi Le-Fluxergy, i-cartridge yokuhlola elebhu ku-chip, i-Fluxergy analyzer, kanye nesofthiwe ye-Fluxergy Works eqhuba inqubo yokuhlola ukuze ubuke futhi utolike idatha yokuhlola.Amakhadi e-Fluxergy ane-multi-modal (okusho ukuthi izinhlobo ezahlukene zokuhlolwa kokuxilonga zingenziwa ngesikhathi esisodwa, njenge-PCR, i-immunochemistry, i-chemistry, njll.) futhi akhiqizwa futhi aklanywa kusetshenziswa ibhodi lesifunda eliphrintiwe (PCB), okuwenza abe ngokwedlulele. kuqiza kahle.kanye nokwandiswa.I-Microfluidics.I-Fluxergy Works ivumela izinhlangano ukuthi zixhume amadivaysi amaningi efwini njengoba inethiwekhi ingasekela.
Ikhithi Yokuhlola ye-Fluxergy POC PCR COVID-19 itholakala kuphela ukuze ithengwe emakethe ye-EU nanoma iyiphi enye imakethe eyamukela ukumakwa kwe-CE njengokugunyazwa ngokomthetho okusemthethweni.
I-Fluxergy futhi yakha iphaneli yokuphefumula engena-CLIA, iphaneli yokuvuvukala, futhi ihweba ngemikhiqizo eminingana yezimakethe zezilwane ezilinganayo kanye nezimakethe zokuphepha kokudla.
Thinta umbhali: Imininingwane yokuxhumana nolwazi olutholakalayo lokuxhumana nabantu lufakwe ekhoneni eliphezulu kwesokudla kukho konke ukukhishwa kwezindaba.
© Copyright 1997-2015, Vocus PRW Holdings, LLC.I-Vocus, i-PRWeb ne-Publicity Wire yizimpawu zokuthengisa noma izimpawu zokuthengisa ezibhalisiwe ze-Vocus, Inc. noma i-Vocus PRW Holdings, LLC.


Isikhathi sokuthumela: Sep-11-2022